Greg Chen

I am interested in the ways in which data-driven science and high-throughput technologies can improve our understanding of health and disease.

I completed my MD/PhD in Genomics and Computational Biology at the University of Pennsylvania. My PhD involved the use of molecular technologies such as single-cell methods to better understand and improve Chimeric Antigen Receptor (CAR) T-cell therapy for the treatment of cancer. Before joining Penn, I studied at McMaster University, during which I performed computational biology research in the McMaster Department of Chemistry & Chemical Biology as well as at the Ontario Institute for Cancer Research and Princess Margaret Cancer Centre with investigators at the University of Toronto.